The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 28174108 |
12 |
Parallel fluorescent probe synthesis based on the large-scale preparation of BODIPY FL propionic acid. |
Takeda Pharmaceutical |
| 27236015 |
60 |
Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonists. |
Daegu-Gyeongbuk Medical Innovation Foundation |
| 25978072 |
53 |
Synthesis and Biological Evaluation of Cyclopentaquinoline Derivatives as Nonsteroidal Glucocorticoid Receptor Antagonists. |
TBA |
| 23656512 |
30 |
1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptora. |
Chinese Academy of Sciences |
| 23448346 |
26 |
Synthesis of novel estrogen receptor antagonists using metal-catalyzed coupling reactions and characterization of their biological activity. |
University of Kansas Medical Center |
| 24040486 |
30 |
Identification of Potent and Selective Diphenylpropanamide ROR? Inhibitors. |
New York University School of Medicine |
| 21218783 |
117 |
Identification of diaryl ether-based ligands for estrogen-related receptora as potential antidiabetic agents. |
Johnson & Johnson Pharmaceutical Research and Development |
| 17482813 |
42 |
ERbeta ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor beta-selective ligands. |
Wyeth Research |
| 15509154 |
24 |
Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha. |
X-Ceptor Therapeutics |
| 30657313 |
204 |
Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-? Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer. |
Daegu-Gyeongbuk Medical Innovation Foundation |
| 31097997 |
21 |
Identification of New Small-Molecule Inducers of Estrogen-related Receptor ? (ERR?) Degradation. |
Jinan University |
| 28525844 |
11 |
The discovery of novel, potent ERR-alpha inverse agonists for the treatment of triple negative breast cancer. |
Qilu University of Technology |
| 28735214 |
54 |
Indazole-based ligands for estrogen-related receptor ? as potential anti-diabetic agents. |
Janssen Research and Development |
| 18680359 |
66 |
Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds. |
Moffitt Cancer Center |
Search and Browse
